These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16284387)

  • 1. Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer.
    Bhandare D; Nayar R; Bryk M; Hou N; Cohn R; Golewale N; Parker NP; Chatterton RT; Rademaker A; Khan SA
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2620-7. PubMed ID: 16284387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.
    Fabian CJ; Kamel S; Zalles C; Kimler BF
    J Cell Biochem Suppl; 1996; 25():112-22. PubMed ID: 9027607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.
    Fabian CJ; Zalles C; Kamel S; Zeiger S; Simon C; Kimler BF
    J Cell Biochem Suppl; 1997; 28-29():101-10. PubMed ID: 9589354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
    Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal lavage findings in women with known breast cancer undergoing mastectomy.
    Khan SA; Wiley EL; Rodriguez N; Baird C; Ramakrishnan R; Nayar R; Bryk M; Bethke KB; Staradub VL; Wolfman J; Rademaker A; Ljung BM; Morrow M
    J Natl Cancer Inst; 2004 Oct; 96(20):1510-7. PubMed ID: 15494601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
    Patil DB; Lankes HA; Nayar R; Masood S; Bryk M; Hou N; Rademaker A; Khan SA
    Breast Cancer Res Treat; 2008 Nov; 112(2):327-33. PubMed ID: 18097749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.
    Mitchell G; Antill YC; Murray W; Kirk J; Salisbury E; Lindeman GJ; Di Iulio J; Milner AD; Devereaux L; Phillips KA
    Breast Cancer Res; 2005; 7(6):R1122-31. PubMed ID: 16457692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer.
    Cazzaniga M; Severi G; Casadio C; Chiapparini L; Veronesi U; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1311-5. PubMed ID: 16835329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis.
    Ozanne EM; Esserman LJ
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2043-52. PubMed ID: 15598759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient variables that predict atypical cytology by nipple duct lavage.
    Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
    Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal lavage in the high-risk patient.
    Francescatti DS; Kluskens L; Shah L
    Am J Surg; 2005 Mar; 189(3):340-1. PubMed ID: 15792764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
    Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
    Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins.
    Gann PH; Geiger AS; Helenowski IB; Vonesh EF; Chatterton RT
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):39-44. PubMed ID: 16434584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk.
    Kurian AW; Mills MA; Jaffee M; Sigal BM; Chun NM; Kingham KE; Collins LC; Nowels KW; Plevritis SK; Garber JE; Ford JM; Hartman AR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1082-9. PubMed ID: 15894656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
    Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
    Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability.
    Gann P; Chatterton R; Vogelsong K; Dupuis J; Ellman A
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):421-8. PubMed ID: 9184775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
    Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
    Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-tissue sampling for risk assessment and prevention.
    Fabian CJ; Kimler BF; Mayo MS; Khan SA
    Endocr Relat Cancer; 2005 Jun; 12(2):185-213. PubMed ID: 15947097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.